Bringing everything together in parallel looks to be a very tricky dance.
I too do agree a Q&A should be held, I have no doubt Joe could answer most questions in a back n forth exchange.
I'm here for the commissioning of P2+ so based on my strategy a tanking SP in the short term presents what I see as a final opportunity (not advice), but nevertheless JW should really endeavour to make this whole process as transparent as he feasibly can rather than a couple of lines in a quarterly.
Other than than, we wait while boxes get ticked...
- Forums
- ASX - By Stock
- LPD
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
LPD
lepidico ltd
Add to My Watchlist
0.00%
!
0.2¢

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-32
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.17M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LPD (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online